• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [22831 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2012     Blue Cross Blue Shield Association (BCBS) Sequencing-based tests to determine fetal down syndrome (trisomy 21) from maternal plasma DNA
2010     National Institute for Health and Care Excellence (NICE) SeQuent Please balloon catheter for in-stent coronary restenosis
2005     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Sequential antibiotic treatment of pneumonia - primary research
2015     NIHR Horizon Scanning Centre (NIHR HSC) Seralite® for multiple myeloma and other B cell dyscrasias
2012     NIHR Horizon Scanning Centre (NIHR HSC) Serelaxin for acute decompensated heart failure – in addition to IV diuretics
2015     NIHR Horizon Scanning Centre (NIHR HSC) Serenity System® to treat tinnitus
2002     Blue Cross Blue Shield Association (BCBS) Serial endpoint testing for the diagnosis and treatment of allergic disorders
2011     HAYES, Inc. Serial Transverse Enteroplasty (STEP) for short bowel syndrome
2017     Adelaide Health Technology Assessment (AHTA) Serious adverse events associated with HPV vaccination
2019     Adelaide Health Technology Assessment (AHTA) Serious adverse events associated with influenza vaccination
2020     Adelaide Health Technology Assessment (AHTA) Serious adverse events associated with oral cholera vaccination
2020     Adelaide Health Technology Assessment (AHTA) Serious adverse events associated with yellow fever vaccination
2003     HAYES, Inc. Serologic assays for the diagnosis and management of inflammatory bowel disease
2013     HAYES, Inc. Serological assays for the diagnosis and management of inflammatory bowel disease: crohn's disease
2013     HAYES, Inc. Serological assays for the diagnosis and management of inflammatory bowel disease: ulcerative colitis
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Serum Anti-Mullerian Hormone (AMH) as ovarian reserve marker
2002     Institute for Clinical Systems Improvement (ICSI) Serum antibodies for the diagnosis of inflammatory bowel disease (IBD): pANCA for ulcerative colitis (UC) and ASCA for Crohn's disease (CD)
2006     HAYES, Inc. Serum carcinoembryonic antigen (CEA) assay for diagnosis of ovarian cancer
2012     Agency for Healthcare Research and Quality (AHRQ) Serum free light chain analysis for the diagnosis, management, and prognosis of plasma cell dyscrasias
2003     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Serum markers of fibrosis and inflammation in chronichepatitis C - systematic review, expert panel
2004     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Serum markers of fibrosis and inflammation in chronichepatitis C - update of previous report
2007     NIHR Horizon Scanning Centre (NIHR HSC) Serum procalcitonin (PCT) as a marker of bacterial lower respiratory tract infection: horizon scanning technology briefing
2008     Quality Improvement Scotland (NHS QIS ) Service delivery organisation for acute low back pain
2024     NIHR Health Services and Delivery Research programme Service design for children and young people with common mental health problems: literature review, service mapping and collective case study
2003     Adelaide Health Technology Assessment (AHTA) Service improvement tools for the prevention, diagnosis and management of chronic diseases
2015     NIHR Health Services and Delivery Research programme Service user engagement and health service reconfiguration: a rapid evidence synthesis
2000     Israel Center for Technology Assessment in Health Care (ICTAHC) Setting priorities for the adoption of health technologies on a national level - the Israeli experience
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Sevelamer for the treatment of hyperphosphatemia in patients with chronic renal failure
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Sevelamer hydrochloride for the treatment of patients with chronic kidney disease: a review of the clinical effectiveness
2006     Canadian Agency for Drugs and Technologies in Health (CADTH) Sevelamer in patients with end-stage renal disease: a systematic review and economic evaluation
2012     Institute for Clinical Evaluative Sciences (ICES) Seven more years: the impact of smoking, alcohol, diet, physical activity and stress on health and life expectancy in Ontario
2013     Health Quality Ontario (HQO) Severity assessment tools for patients with community-acquired pneumonia: a rapid review
2002     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Sex change surgery - expert panel. IPE-02/i
2004     HAYES, Inc. Sex reassignment surgery and associated therapies for the treatment of gender identity disorder
2014     HAYES, Inc. Sex reassignment surgery for the treatment of gender dysphoria
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Sexual Assault Nurse Evaluation (SANE) rape crisis procedure: clinical effectiveness and guidelines
2010     Institute of Health Economics (IHE) Sexual exploitation of children and youth over the internet: a rapid review of the scientific literature
2013     Medical Services Advisory Committee (MSAC) Sexual health medicine consultation items
2015     NIHR Public Health Research (PHR) programme Sexual health promotion for young people delivered via digital media: a scoping review
2004     Agency for Healthcare Research and Quality (AHRQ) Sexuality and reproductive health following spinal cord injury
2022     Agency for Care Effectiveness (ACE) SGLT2 inhibitors for treating heart failure with reduced ejection fraction and chronic kidney disease
1997     VA Technology Assessment Program (VATAP) Shared decision-making programs: a descriptive analysis of experience with shared decision-making programs in VA. A systematic review: assessing the effectiveness of shared decision-making programs for prostate care
2016     Penn Medicine Center for Evidence-based Practice (CEP) Shared governance for nursing assistants and other ancillary medical staff in the hospital setting
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Shared medical appointments (SMAs) for type 2 diabetes management
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Sharp and round optic edges of intraocular lenses: a review of the clinical and cost-effectiveness
2014     NIHR Horizon Scanning Centre (NIHR HSC) Sheffield Support Snood for neurodegenerative conditions
2004     VA Technology Assessment Program (VATAP) Shelf-life of stored sterilized materials: should VHA adopt expiration dating or event-related outdating?
2015     Health Council of the Netherlands Gezondheidsraad (GR) Shiftwork and health risks: possibilities for prevention
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Shilla and MAGEC systems for growing children with scoliosis: cost-effectiveness and clinical benefits
2022     NIHR Health Technology Assessment programme Shock-absorbing flooring for fall-related injury prevention in older adults and staff in hospitals and care homes: the SAFEST systematic review
2022     NIHR Health Technology Assessment programme Short course daily prednisolone therapy at the time of upper respiratory tract infection in children with relapsing steroid sensitive nephrotic syndrome; the PREDNOS 2 study
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Short- and long-term use of benzodiazepines in patients with generalized anxiety disorder: a review of guidelines
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Short-acting agents for procedural sedation and analgesia in Canadian emergency departments: a review of clinical outcomes and economic evaluation
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Short-acting insulin analogues for diabetes mellitus: meta-analysis of clinical outcomes and assessment of cost-effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Short-acting intramuscular olanzapine for acute agitation: clinical and cost - effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Short-acting intramuscular olanzapine for acute agitation: clinical and cost - effectiveness and guidelines
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Short-acting spinal anesthetics for outpatient procedures: a review of the clinical evidence and guidelines
2006     National Institute for Health and Care Excellence (NICE) Short-term circulatory support with left ventricular assist devices as a bridge to cardiac transplantation or recovery
2013     Health Quality Ontario (HQO) Shorter versus longer duration of antibiotic therapy in patients with community-acquired pneumonia: a rapid review
2005     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) Should one or two embryos be transferred in IVF? A health technology assessment
2000     Centre for Clinical Effectiveness (CCE) Should prophylatic routine anti-coagulant therapy be used before and after hysterectomies when no other risk factors are known?
2004     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Should the French breast cancer screening programme be extended to women aged 40-49? Update
2002     Technology Assessment Unit of the McGill University Health Centre (MUHC) Should the McGill University Health Center replace the Jelco/Cathlon catheter by the ProtectIVPlus catheter for intravenous infusions?
2002     Technology Assessment Unit of the McGill University Health Centre (MUHC) Should the McGill University Health Center use mitoxantrone in the treatment of multiple sclerosis?
2002     Technology Assessment Unit of the McGill University Health Centre (MUHC) Should the McGill University Health Centre initiate an antiviral treatment programme for patients with chronic hepatitis C?
2006     Technology Assessment Unit of the McGill University Health Centre (MUHC) Should the McGill University Health Centre use safety devices to reduce needlestick injuries associated with intravascular infusions?
2003     Technology Assessment Unit of the McGill University Health Centre (MUHC) Should the MUHC approve the use of colorectal stents?
2003     Technology Assessment Unit of the McGill University Health Centre (MUHC) Should the MUHC approve the video capsule endoscopy system in the diagnosis of small bowel abnormalities?
2003     Technology Assessment Unit of the McGill University Health Centre (MUHC) Should the MUHC use low-molecular-weight heparin in inpatient treatment of deep vein thrombosis with or without pulmonary embolism?
2000     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Shoulder arthroplasty in indications for degenerative or traumatologic processes. IPE-00/25 (Public report)
2010     National Institute for Health and Care Excellence (NICE) Shoulder resurfacing arthroplasty
2010     HAYES, Inc. Shoulder resurfacing for treatment of arthritis and degenerative joint disease
2001     Centre for Clinical Effectiveness (CCE) Shoulder supports in patients with hypotonicity following stroke
2012     HAYES, Inc. Sialoendoscopy for salivary gland stones
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Sibutramine
2004     The Swedish Council on Health Technology Assessment (SBU) Sickness absence - causes, consequences and practices
2004     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Sickness certification: current situation and proposals for improving practice
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Side rails on beds in long-term and residential care facilities: safety and evidence based guidelines
2011     HAYES, Inc. Signal-Averaged Electrocardiogram (SAECG) to identify risk of ventricular tachyarrhythmias and sudden cardiac death
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sildenafil (Revatio) 10mg/ml powder for oral suspension
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sildenafil (Revatio®) for the treatment of pulmonary arterial hypertension (WHO functional class II or III) to improve exercise capacity
2010     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sildenafil citrate (Revatio®) solution
2004     NIHR Horizon Scanning Centre (NIHR HSC) Sildenafil citrate for adult pulmonary arterial hypertension - horizon scanning review
2002     HAYES, Inc. Sildenafil citrate for sexual dysfunction
2002     NIHR Horizon Scanning Centre (NIHR HSC) Sildenafil for female sexual arousal disorder - horizon scanning review
1998     West Midlands Health Technology Assessment Collaboration (WMHTAC) Sildenafil: an oral drug for the treatment of male erectile dysfunction
1996     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Silicon breast implants
2023     Belgian Health Care Knowledge Centre (KCE) Silicone adhesive multilayer foam dressings to prevent hospital-acquired pressure ulcers: a Belgian RCT-based economic evaluation
1996     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Silicone gel breast implants
2009     NIHR Horizon Scanning Centre (NIHR HSC) Silodosin for benign prostatic hyperplasia
2010     Penn Medicine Center for Evidence-based Practice (CEP) Silver coated dressings for prevention of surgical site infections in cardiac surgery patients
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Silver dressings for the treatment of patients with infected wounds: a review of clinical and cost-effectiveness
2008     HAYES, Inc. Silver-coated urinary catheters for prevention of urinary tract infections
2007     HAYES, Inc. Silver-coated urinary catheters for prevention of urinary tract infections
2020     NIHR Health Technology Assessment programme Silver-impregnated, antibiotic-impregnated or non-impregnated ventriculoperitoneal shunts to prevent shunt infection: the BASICS three-arm RCT
2005     Adelaide Health Technology Assessment (AHTA) SilverHawk (TM) Peripheral Plaque Excision System: percutaneous peripheral atherectomy for patients with peripheral vascular disease
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Simeprevir (Galexos — Janssen Inc.) indication: chronic hepatitis C genotype 1 infection
2012     NIHR Horizon Scanning Centre (NIHR HSC) Simeprevir for chronic hepatitis C infection
2012     NIHR Horizon Scanning Centre (NIHR HSC) Simeprevir for hepatitis C – first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Simeprevir in combination with sofosbuvir (with or without ribavirin) for chronic hepatitis C